|
Daratumumab, Bortezomib and Dexamethasone (DVd) vs Bortezomib and Dexamethasone (Vd) in RRMM Based on Prior Lines and Treatment Exposure: CASTOR |
|
|
|
Titel: |
Daratumumab, Bortezomib and Dexamethasone (DVd) vs Bortezomib and Dexamethasone (Vd) in RRMM Based on Prior Lines and Treatment Exposure: CASTOR |
Auteur: |
Lentzsch, Suzanne Nooka, Ajay Quach, Hang Lee, Cindy Barreto, Wolney Corradini, Paolo Min, Chang Ki Scott, Emma Chanan-Khan, Asher Horvath, Noemi Capra, Marcelo Beksac, Meral Ovilla, Roberto Jo, Jae-Cheol Shin, Ho-Jin Soong, David Casneuf, Tineke Chiu, Christopher Qin, Xiang Amin, Himal Sonneveld, Pieter Schecter, Jordan Sasser, Kate Qi, Ming Mateos, Maria-Victoria |
Verschenen in: |
Clinical lymphoma myeloma and leukemia |
Paginering: |
Jaargang 17 (2017) nr. 1S pagina's 1 p. |
Jaar: |
2017 |
Inhoud: |
|
Uitgever: |
Published by Elsevier B.V. |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|